Plain-English translation of NCT06941116 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether a steroid-based blood screening method can more accurately detect primary aldosteronism—a specific type of high blood pressure that may be curable—in people who are already taking blood pressure medications. Right now, doctors typically ask patients to stop or switch their medications before screening, which can be risky and complicated. This study wants to see if the new blood test method works better while patients stay on their regular medications.
Many people with high blood pressure actually have a treatable form called primary aldosteronism, but it often goes undiagnosed because current screening requires stopping medications, which can be unsafe. This trial aims to develop a simpler, safer screening method that works while patients continue taking their regular blood pressure drugs.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital twice for blood tests. During your first visit, you'll have blood drawn while continuing to take your regular blood pressure medications. Then, if it's safe for you, you'll temporarily stop or switch your medications as directed. At your second visit, you'll have another blood sample taken in this adjusted state. The blood samples will be analyzed to measure hormone levels using specialized lab techniques. The whole process aims to compare how well the new steroid-based test works compared to the current standard method.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
China